Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Interest Coverage Ratio (2023 - 2026)

Adaptin Bio (APTN) posted Interest Coverage Ratio of 588.86 for Q1 2026, down 4930.93% sequentially from 11.7 in Q1 2025, and down 4930.93% YoY from 12.19 in Q1 2025.

Adaptin Bio (APTN) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

Adaptin Bio has reported Interest Coverage Ratio for 4 years, with the latest figure at 588.86 in Q1 2026.

  • Quarterly Interest Coverage Ratio fell 4930.93% year-over-year to 588.86 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2938.05 (down 35125.68% YoY) and the FY2025 annual result came in at 2.68, up 16.62% from the prior year.
  • Interest Coverage Ratio slipped to 588.86 in Q1 2026 per APTN's latest filing, from 11.7 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 0.96 in Q4 2023 and troughed at 588.86 in Q1 2026.
  • A 4-year average of 91.08 and a median of 9.34 in 2024 frame the typical range for Interest Coverage Ratio.
  • The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio tumbled 54.49% in 2025, then sank 4930.93% in 2026.
  • Over 4 years, Interest Coverage Ratio stood at 0.96 in 2023, then plunged by 261.27% to 3.48 in 2024, then slumped by 236.08% to 11.7 in 2025, then tumbled by 4930.93% to 588.86 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods registered 588.86, 11.7, and 3.48 for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -255.67
Mar 31, 2026 -588.86
Mar 31, 2025 -11.70
Dec 31, 2024 -3.48
Sep 30, 2024 -9.34
Jun 30, 2024 -15.65
Mar 31, 2024 -7.58
Dec 31, 2023 -0.96